The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if this pans out to be as good in large phase three studies as it has been in phase two the only thing that would stand in the way of this displacing every Statin on the planet is cost because you'd have equal or better lipid lowering efficacy and instead of having a small increase in the risk of type 2 diabetes you would be patently reducing that risk
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.